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2 
INVESTIGATING INNOVATIVE MATERIAL SHIFTS IN MEDICAL PRODUCTS TO 27 
REDUCE ENVIRONMENTAL IMPACTS: FOCUS ON BIOPOLYMERS 28 
29 
Abstract 30 
While petroleum-based plastics are extensively used in healthcare settings, recent developments 31 
in biopolymer manufacturing processes have created new avenues and opportunities for 32 
increased integration of biopolymers into medical products, devices, and services. This paper 33 
assessed opportunities for using three different biopolymers in healthcare and the resultant 34 
comparative environmental impacts of single use disposable devices with increased biopolymer 35 
content vs. typically manufactured devices in hysterectomy procedures. This study performed a 36 
comparative life cycle assessment of single-use-disposable medical products containing 37 
plastic(s) versus the same single-use medical devices with biopolymers substituted for plastic(s). 38 
The context of this life cycle assessment (LCA) was that of Magee-Womens Hospital (Magee) in 39 
Pittsburgh, PA, and the products used in four types of hysterectomies performed at Magee that 40 
contained plastics potentially suitable for biopolymer substitution. Magee is a 360-bed teaching 41 
hospital, which performs approximately 1400 hysterectomies annually. Individual participants 42 
were not applicable to this study. Rather, medical products used in the hysterectomies were the 43 
focus of this study. There are life-cycle environmental impact tradeoffs when substituting 44 
bioplastics for petroplastics in operating room procedures such as hysterectomies. The 45 
substitution of biopolymers for petroleum-based plastics increased smog-related impacts by 46 
approximately 900% for laparoscopic and robotic hysterectomies, and increased ozone 47 
depletion-related impacts by approximately 125% for laparoscopic and robotic hysterectomies. 48 
Conversely, biopolymers reduced life-cycle human health impacts, acidification and cumulative 49 
energy demand for the four hysterectomy procedures. The integration of biopolymers into 50 





medical products is correlated with reductions in carcinogenic impacts, non-carcinogenic 51 
impacts, and respiratory effects. However, the significant agricultural inputs associated with 52 
manufacturing biopolymers exacerbates environmental impacts of products and devices made 53 




a. Background 58 
 59 
It was not until the 1960s that plastics became so pervasively used in healthcare (Greene, 60 
1986). At this time, the healthcare industry learned how to substitute polyvinyls, polycarbonates, 61 
and polystyrenes for materials originally made out of glass, rubber, metal, and woven textiles 62 
(Greene, 1986). The substitution occurred primarily because medical device manufacturing 63 
companies learned to make devices with plastics efficiently and cheaply. These factors led to 64 
increases in healthcare plastic use, which consequentially led to fundamental changes in the 65 
processes that governed medical device manufacturing, use, and disposal. For example, before 66 
the substitution of petroleum-based plastics, medical products made of woven-cotton would 67 
undergo cleaning on-site at the hospital once they were used (Greene, 1986). Following the 68 
substitution of petroleum-based plastics, devices made of plastic that fulfilled the same function 69 
would be disposed after being used only one instance; which consequently led to increased 70 
quantities of waste created by hospitals. 71 
 72 





Over the past half-century, plastics have become a ubiquitous material in the medical 73 
device industry. In a study analyzing environmental impact of seven single-use medical devices 74 
undergoing reprocessing, all had some form of polyethylene in each of their respective bill of 75 
materials (Unger & Landis, 2015). Total polyethylene weight ranged anywhere from 7% to 88% 76 
of total weight for individual devices, and made up 52% of total weight for the combined 77 
average of the seven devices (Unger & Landis, 2015). In another study of four types of 78 
hysterectomy (abdominal, vaginal, laparoscopic, robotic), plastics were again found to be a 79 
significant portion of the operating room (OR) waste stream. The study concluded that the 80 
plastics used (e.g., thin film packaging wrappers, hard plastic trays) accounted for a minimum of 81 
36% of material solid waste (MSW) by weight for vaginal hysterectomies and a maximum of 82 
46% of MSW by weight for robotic procedures (Thiel et al., 2014). 83 
 84 
While petroleum-based plastics are extensively used in healthcare settings, bio-plastics 85 
for the past several decades have also formed their own niche market in the healthcare industry. 86 
As opposed to petroleum-based plastics that obtain their carbon from non-renewable resources 87 
(e.g., petroleum), bio-plastics (a.k.a. biopolymers) are plastics in which some or all of the 88 
polymer is derived from renewable feedstocks. With regards to healthcare applications, recent 89 
developments in biopolymer manufacturing processes have created new avenues and 90 
opportunities for increased integration of biopolymers into medical products, devices, and 91 
services (Auras, Lim, Selke, & Tsuji, 2011). On. One factor that has contributed to these 92 
opportunities is that newly developed biopolymers are able to retain similar physical 93 
characteristics of synthetic plastics. For example, emerging studies show that guayule-derived 94 
latex rubber is a suitable substitute for flexible plastics and traditional rubber products (Cornish, 95 





Williams, Hall, & III, 2008; Rasutis, Soratana, McMahan, & Landis, 2015). Another study 96 
shows that the biopolymer polylactide (PLA) is a suitable substitute for different forms of plastic 97 
(Madhavan Nampoothiri, Nair, & John, 2010). Based on the material and chemical properties of 98 
PLA, the study concluded that PLA has many potential applications, including upholstery, 99 
disposable garments, awnings, feminine hygiene products, and diapers (Madhavan Nampoothiri 100 
et al., 2010). One of the benefits of PLA is that it is compostable, and might allow hospitals to 101 
decrease the amount of plastics in their respective waste streams (Ghorpade, Gennadios, & 102 
Hanna, 2001).  103 
 104 
Given recent development in the field of biopolymers and their potential to replace 105 
commonly used plastics, there is the possibility to use biopolymers in a variety of medical 106 
products. Replacing petroleum-based plastics with biopolymers would not only reduce depletion 107 
of non-renewable resources, but could also reduce hospital-generated material solid waste 108 
(MSW) and regulated medical waste (RMW) if the biopolymers are composted; however, a 109 
systems approach is needed to discern any potential net gain (or losses) from a life cycle 110 
perspective.  Such a replacement would contribute to the trend of hospitals placing a higher 111 
emphasis on sustainability initiatives. The foci of these sustainability initiatives include (but are 112 
not limited to) a hospital’s efficient use of materials, energy efficiency, water efficiency, green 113 
purchasing, and waste diversion strategies (Janet, 2013; Kaplan et al., 2012; Kwakye, Brat, & 114 
Makary, 2011). Moreover, an assessment of the environmental impacts of increased biopolymer 115 
use in favor of petroleum-based plastics in medical devices and products has not yet been 116 
performed. This study addresses this knowledge gap by comparing the environmental impacts of 117 
medical devices composed of plastics versus the same medical devices made with biopolymers.  118 






The methods section parallels the four major steps of a life cycle assessment (LCA) (i.e., 120 
goal and scope definition, inventory analysis, impact assessment, interpretation) as described by 121 
the ISO 14040 series. LCAs are used to assess environmental impacts throughout a product's life 122 
and seek to address a number of environmentally related concerns, including: compilation of 123 
energy and material input and outputs; evaluation of potential impacts attributed to the inputs and 124 
outputs; and, interpretation of the results to help make a more informed decision (EPA, 2010). In 125 
addition to the LCA, a 23 factorial experiment was used to demonstrate the environmental and 126 
human health impacts resulting from different biopolymer substitutions.  127 
 128 
b. Scope and System Boundary 129 
 130 
This study presents a comparative life cycle assessment of single-use-disposable medical 131 
products containing plastic(s) versus the same single-use medical devices with biopolymers 132 
substituted for plastic(s). The context of this LCA was that of Magee-Womens Hospital (Magee) 133 
in Pittsburgh, PA, and the products used in four types of hysterectomies performed at Magee that 134 
contained plastics potentially suitable for biopolymer substitution. Magee is a 360-bed teaching 135 
hospital, which performs approximately 1400 hysterectomies annually. The products and devices 136 
evaluated are those used in four types of hysterectomy (i.e., vaginal, abdominal, laparoscopic, 137 
robotic) at Magee. Vaginal hysterectomy is a procedure where the uterus and/or cervix are 138 
removed through the vagina, and abdominal hysterectomy results in uterus and/or cervix being 139 
removed from lower abdomen (Dicker et al., 1982). Laparoscopic and robotic hysterectomies are 140 





both minimally invasive and utilize cameras and 3-D views to remove the uterus and/or cervix 141 
(Sarlos, Kots, Stevanovic, & Schaer, 2010). 142 
 143 
Waste audits of 62 hysterectomies were conducted by Thiel et al (2014) (15 each 144 
abdominal, vaginal, and robotic, and 17 laparoscopic). The waste audits were done to collect the 145 
material inputs and to quantify and characterize the products and materials entering Magee’s 146 
municipal solid waste, recycling streams, and regulated medical waste (RMW). The number of 147 
medical devices and products used in each type of hysterectomy and the quantity of plastic(s) 148 
within each product were included in the analysis using the inventory data collected in a previous 149 
study (Thiel et al., 2014). Figure 1 shows that plastics are the most significant portions by weight 150 
of MSW per procedure for all types of hysterectomies. When averaging the total waste from the 151 
four hysterectomies, polypropylene, polyvinylchloride, and various forms of hard plastic 152 
represented the greatest sources of produced waste by mass. On a percent basis by mass, 153 
polypropylene, polyvinylchloride, and hard plastic represented 32%, 25%, and 14%, 154 
respectively, of the total waste produced by the four hysterectomies (Thiel et al., 2014). Figure 1 155 
also shows that robotic hysterectomies typically consume more materials than the other three 156 
hysterectomies.  157 
 158 






Figure 1. Average Material Composition of Municipal Solid Waste from a Single 160 
Hysterectomy by Surgery Type with Assumed Biopolymer Substitution. Adapted from 161 
(Thiel et al., 2014). 162 
(Caption Text) This figure shows an average of the waste produced from the four hysterectomy 163 
procedures. Materials substituted for biopolymers are colored shades of blue, and non-substituted 164 
materials are colored shades of orange. Similarly, all materials with (Substituted) following their 165 
name are materials that were substituted for biopolymers. All materials with (Not Substituted) 166 
following their names are materials that were not substituted for biopolymers. 167 
 168 
Specific types of biopolymers were designated as substitutions to replace the plastics 169 
found in each device. The choice of substituted biopolymer was based on which biopolymer has 170 
appropriate material and functional properties to that of the original plastic. The functional unit 171 
was all medical devices that contained petroleum-based plastics suitable for biopolymer 172 





substitution for each of the four types of hysterectomies. The system boundary encompassed 173 
activities associated with the raw material extraction, production, use, and end-of-life (EOL) for 174 
the products containing plastic in each type of hysterectomy. 175 
 176 
Table 1. Potential Biopolymer Substitutions for Petroleum Plastics used in Hysterectomy 177 
Procedures. Adapted from (Thiel et al., 2014). 178 
Material found in 





used in figures) 
Product Device 
Low-density 
polyethylene (LDPE) PLA (P) Laparotomy drape 
8 mm bladeless 
obturator 
Polypropylene PLA (P) 
Gowns; laparotomy 
drapes; bare warm air 
drape; blue drape; blue 
wrap 
None 
Polyisoprene Guayule-derived latex (G) Tan glove; blue glove None 
Nitrile Guayule-derived latex (G) Purple glove None 
Neoprene Guayule-derived latex (G) Green glove None 
Cardboard Thermoplastic starch (T) Bare warm air drape None 
(Caption Text) Materials found in products and/or devices for robotic, abdominal, laparoscopic, 179 
and vaginal hysterectomies performed at Magee. Plastic, product, and device information is from 180 
(Thiel et al., 2014). The potential biopolymer substitution was determined for the purposes of 181 
this study based on biopolymers with similar characteristics. 182 
 183 
c. Inventory Analysis 184 
 185 





The following plastics were identified in the four types of hysterectomies at Magee: low-186 
density polyethylene (LDPE), polypropylene (PP), polyisoprene, nitrile, and neoprene. Based on 187 
their physical properties and delivered function, the weights of plastics found in each device 188 
were substituted with an equal weight of suitable biopolymers (see Supplementary Information). 189 
Guayule-derived latex was substituted for all products and/or devices containing nitrile, 190 
neoprene, polyisoprene. Life cycle inventory data for guayule-derived latex was derived from 191 
Rasutis et al., 2015 (Rasutis et al., 2015). PLA was substituted for all products and/or devices 192 
containing LDPE and polypropylene. Life cycle inventory data for PLA was derived from Vink 193 
et al., 2010 (Vink, Davies, & Kolstad, 2010). Thermoplastic starch was substituted for all 194 
products containing cardboard. While cardboard is considerable a renewable material, 195 
thermoplastic starch was substituted because of its suitability as a cardboard substitute. Life 196 
cycle inventory data for thermoplastic starch were derived from existing ecoinvent v2.2 data, 197 
under the classification “Modified starch, at plant/RER U” (Weidema & Hischier, 2012). 198 
 199 
PLA is a suitable LDPE substitute, as PLA has properties that make it appropriate for thin 200 
film applications including disposable products and packaging. Research is continuing to expand 201 
the number of applications for PLA as the potential material characteristics are broadened 202 
(Reddy, Vivekanandhan, Misra, Bhatia, & Mohanty, 2013; Shen, Haufe, & Patel, 2009). Similar 203 
to LDPE, PP in film applications and packaging can be replaced with disposable PLA products 204 
(Shen, Worrell, & Patel, 2010). Regarding this study, PLA’s GHG emissions included direct site 205 
emissions, indirect emissions from electricity production, fuel, material, corn production, and 206 
reclamation, as well as biogenic CO2 uptake from the corn feedstock. These emissions are 207 
considered within the timeframe of the global warming potential (GWP) impact category. Starch 208 





is well established as a low cost material for packaging applications, which can be blended with 209 
cardboard and other fibers to achieve a wide range of application specific properties. While 210 
cardboard is an effective biobased material, starch may perform favorably and a comparison of 211 
environmental impacts will help assess any tradeoffs that exist (Bastioli, 1998; Mohammadi 212 
Nafchi, Moradpour, Saeidi, & Alias, 2013; Shen et al., 2009). Clinical and performance trials 213 
have also shown that guayule-derived latex have high molecular weights, and products made 214 
from guayule-derived latex have desirable performance properties in a clinical setting (Rasutis et 215 
al., 2015). Guayule-derived latex has also been shown to be safe for people with Type I latex 216 
allergy, where typical latex materials (e.g., nitrile, neoprene) contain allergenic proteins that 217 
affect those with Type I latex allergy (Foster & Coffelt, 2005; Siler, Cornish, & Hamilton, 1996). 218 
  219 
d. Impact Assessment 220 
  221 
Environmental and human health impacts resulting from the calculated inputs and outputs 222 
were calculated using the Tool for Reduction and Assessment of Chemical and Other 223 
Environmental Impacts (TRACI) 2.1 (Bare, 2002), which was created by the United States 224 
Environmental Protection Agency (EPA) to assist in impact assessment. TRACI was chosen 225 
because it is the most comprehensive life cycle impact assessment tool applicable to the United 226 
States. The following impacts were calculated and reported from TRACI: ozone depletion, 227 
global warming, smog, acidification, eutrophication, carcinogenics, non-carcinogenics, 228 
respiratory effects, and ecotoxicity. While not included in the TRACI portfolio, cumulative 229 
energy demand was also included as an impact category. 230 





The method to calculate cumulative energy demand (CED) is based on characterization 231 
factors that are assigned to energy resources in 5 impact categories: non-renewable (fossil), non-232 
renewable (nuclear), renewable (biomass), renewable (wind, solar, geothermal), and renewable 233 
(water) (Frischknecht et al., 2007; PRé, 2016). Normalization is not used to calculate CED, 234 
where CED is calculated by assigning a weighting factor of 1 to each impact category 235 
(Frischknecht et al., 2007); PRé (2016).  236 
 237 
e. 23 Factorial Design Experiment 238 
 239 
A 23 factorial experiment was used to demonstrate the variances of environmental and 240 
human health impacts resulting from different substitutions of PLA, guayule-derived latex, and 241 
thermoplastic starch. The 23 factorial design experiment factors were the three substituted 242 
plastics (i.e., PLA, guayule-derived latex, thermoplastic starch) and the two factor levels were 243 
whether or not biopolymers were substituted for the three design experiment factors.  244 
 245 
Results 246 
Figure 2 shows the comparative environmental and human health impacts resulting from 247 
hysterectomies using standard medical products containing petroleum-based plastics and medical 248 
products with biopolymers substituted. For each impact category, the results are normalized to 249 
the hysterectomy with the greatest overall impact when considering both base-case and 250 
biopolymer substitution scenarios. Because the impact categories are normalized for comparative 251 
purposes, the generated values may not necessarily reflect the overall magnitude of impact for 252 
individual impact categories.  253 














Polypropylene or PLA         
Soft Plastic or PLA         
Polyisoprene or PLA       B Biopolymers Substituted 
Nitrile or Guayule-Derived Latex       P Petroleum-Based Plastics 
Neoprene or Guayule-Derived Latex   
EO
L MSW   L Laparoscopic 
Cardboard or Thermo-Plastic Starch   RMW   A Abdominal 
Cotton1       V Vaginal 
PVC1       R Robotic 
Hard Plastic1         
Other Materials12         1Non Substituted Material 258 
2Includes Polystyrene, Steel, Aluminum, Rubber, Paper, Glass, Wood, HDPE, and Polyurethane. All of these materials composed less than 2% 259 
(by weight) of Magee’s total analyzed waste stream. 260 
EOL: End-of-Life; MSW: Material Solid Waste; RMW: Regulated Medical Waste 261 
Figure 2. Normalized TRACI Impacts for Medical Products Containing Petroleum-Based Plastics 262 
versus Medical Products Potentially Containing Biopolymers Used in Hysterectomies. 263 






The use of biopolymers in surgical devices is preferable for several impact categories 265 
compared to petroleum-based plastics which include acidification (19-29%), ecotoxicity (1-2%), 266 
carcinogenics (3-4%), non-carcinogenics (25-61%), respiratory effects (16-25%), and CED (53-267 
84%). However, medical devices with petroleum-based plastics that do not include any quantity 268 
of biopolymers perform better in several other impact categories such as global warming, 269 
eutrophication, ozone depletion, and smog. In particular, the impact category smog for 270 
laparoscopic, abdominal, vaginal and robotic hysterectomy procedures performs better by 86%, 271 
62%, 57% and 86% respectively. While the utilization of biopolymers may offer some life-cycle 272 
based human health benefits, such as vaginal hysterectomies having 61% lower non-carcinogenic 273 
impact, the agricultural activities associated with manufacturing biopolymers exacerbate a 274 
number of environmental impacts.  275 
 276 
Significant agricultural activities are associated with creating biopolymers, where these 277 
agricultural activities exacerbate impacts related to global warming, eutrophication, ozone 278 
depletion, and smog. Much of the smog-related impacts resulting from PLA production occur 279 
during PLA’s fermentation stage, where the fermentation stage is associated with significant 280 
levels of emitted NOX (Auras et al., 2011). Additionally, the transport associated with PLA’s 281 
production drives the majority of PLA’s ozone depletion-related impacts (Auras et al., 2011). On 282 
the other hand, guayule-derived latex and thermoplastic starch are correlated with much lower 283 
levels of ozone-depleting substances during their associated manufacturing processes. Smog 284 
causing emissions result primarily from lactic acid fermentation and agricultural processes on 285 
farm in this model, while ODP results mainly from transportation (Hottle, Bilec, & Landis, 286 





2013).  It is important to note that the inventories used herein pre-date Montreal protocol ozone 287 
depleting substances according to the United States Environmental Protection Agency, Office of 288 
Health, and Environmental Assessment Exposure Assessment Group (1989), and as such we 289 
normalize the results in order to make comparisons.  290 
 291 
 Using results from the 23 factorial design of experiments (DOE), Figure 3 shows the 292 
relative increase or decrease in all impact categories from various combinations of biopolymer 293 
substitutions. The error bars in Figure 3 show the most significant increase or decrease for all 294 
impact categories using values generated from the 23 factorial DOE. The increase of impacts 295 
related to global warming, eutrophication, ozone depletion, and smog resulted when PLA, 296 
guayule-derived latex, and thermoplastic starch were substituted for typically used materials. The 297 
increase of acidification-related impacts resulted when thermoplastic starch was substituted for 298 
cardboard. The increase of ecotoxicity related impacts resulted when PLA and guayule-derived 299 
latex were substituted for typically used materials. Conversely, the decrease of impacts related to 300 
carcinogenics, non-carcinogenics, respiratory effects, and cumulative energy demand resulted 301 
when PLA, guayule-derived latex, and thermoplastic starch were substituted for petroleum-based 302 
materials. The substitution of biopolymers for petroleum-based plastics decreased cumulative 303 
energy demand by approximately 73% and 84% for laparoscopic and robotic hysterectomies, 304 
respectively. The substitution of biopolymers for petroleum-based plastics increased smog-305 
related impacts by approximately 700% and 600% for laparoscopic and robotic hysterectomies, 306 
respectively.  Table S2 through Table S11 in the supplementary information display the DOE 307 
results for all nine impact categories.  308 











Figure 3. Change/Percent Increase or Decrease Resulting from Biopolymer Substitutions 311 
Using Values Generated from 23 Factorial DOE. 312 
(Caption Text) The error bars in Figure 3 show the most significant increase or decrease for all 313 
impact categories using values generated from the 23 factorial DOE. 314 
 315 
Discussion 316 
This study examined the environmental impacts of integrating biopolymers into 317 
hysterectomy products. While there are several noteworthy tradeoffs from a life cycle 318 
perspective, the use of biopolymers in healthcare would require considerable feedback from the 319 
doctors, nurses and patients utilizing the biopolymer products. To evaluate adoption, discourse 320 
with hospital personnel would be necessary to determine the utility advantages and 321 
disadvantages of products containing biopolymers. For example, doctors and nurses may push 322 
back on integrating biopolymers into a certain product because that product requires material 323 
and/or technical specifications that may not be fulfilled by a biopolymer. Conversely, doctors 324 
and nurses may favor biopolymer utilization in a certain healthcare product because that 325 





product’s utility may increase as biopolymers are integrated Kumar, Sivakumar, and Dhurai 326 
(2013). 327 
 Moreover, there are a number of contextual and regulatory factors that would affect the 328 
implementation of biopolymers into healthcare products. These factors include policies and 329 
regulations, financial and regulatory environment, leadership, workflow, carbon literacy, and 330 
support systems. While these factors are typically dependent on individual healthcare providers, 331 
one would expect that workflow would not be significantly affected because the biopolymer 332 
products proposed herein are functionally equivalent and would still be utilized by a healthcare 333 
provider regardless of the level of integrated biopolymers into medical products. Further research 334 
on barriers to adoption, market analysis for biopolymer medical products, as well as supply chain 335 
and feedstock availability would inform any increased usage of biopolymers in healthcare.  336 
 337 
Effective composting of biopolymers used in medical products may decrease 338 
environmental and human health impacts resulting from RMW and MSW, but warrant further 339 
evaluations since there are studies that discuss industrial composing facilities sending 340 
biopolymers to landfills because of the slow degradation rates (Hottle, Bilec, Brown, & Landis, 341 
2015). Primary concerns with composting medical waste include existing regulatory barriers 342 
associated with composting medical waste, as well as the necessary life-cycle processes and 343 
labor required for composting. For example, implementing a composting waste stream at a 344 
hospital would require: healthcare personnel to distinguish compostable from non-compostable 345 
products; consistent upkeep and maintenance of composting bins and equipment to ensure their 346 
sterility in medical environment; and, disassembly of medical products that are only partially 347 
composed of compostable material before those products enter a composting stream. Despite 348 





these concerns, there are waste management options such as anaerobic digesters that could 349 
decrease global warming and energy use by producing methane and energy from bioplastic waste 350 
streams (Hobbs, Devkota, Parameswaran, & Landis, 2016).  351 
 352 
The integration of biopolymers into medical products illustrates reductions in 353 
carcinogenic impacts (3-4%), non-carcinogenic impacts (25-61%), respiratory effects (16-25%), 354 
and cumulative energy demand (53-84%). Cumulative energy demand represents the greatest 355 
potential for environmental impact reduction, particularly because devices made with fossil-fuel 356 
based plastics require higher quantities of electricity to produce when compared to devices made 357 
with biopolymers. However, the significant agricultural inputs associated with biopolymers 358 
exacerbate a number of environmental impacts resulting from products and devices made out of 359 
biopolymers. The results showed that the PLA and guayule-derived latex substitutions resulted in 360 
significant smog-related impacts. Both PLA and guayule-derived latex have smog-related life-361 
cycle impact factors that are at least 40 times greater than that of their respective substituted 362 
plastic (e.g., LDPE for polypropylene, guayule-derived latex for polyisoprene). The substitution 363 
of polypropylene for PLA resulted in the most significant smog-related impacts, where PLA has 364 
a smog life-cycle impact factor that is more than 140 times greater than that of polypropylene. If 365 
the biopolymers are cultivated in a locale with high-levels of existing smog (e.g., urban areas), 366 
the use of biopolymers is not necessarily favorable. On the other hand, if the biopolymers are 367 
cultivated in a locale with low-levels of existing smog (e.g., rural areas), the use of biopolymers 368 
is potentially favorable when considering smog-related impacts.  369 
 370 





There are life-cycle environmental impact tradeoffs when substituting bioplastics for 371 
petroplastics in operating room procedures such as hysterectomies. The substitution of 372 
biopolymers for petroleum-based plastics increased smog-related impacts by approximately 373 
900% for laparoscopic and robotic hysterectomies, and increased ozone depletion-related 374 
impacts by approximately 125% for laparoscopic and robotic hysterectomies. Conversely, 375 
biopolymers reduced life-cycle human health impacts, acidification and cumulative energy 376 
demand for the four hysterectomy procedures. The integration of biopolymers into medical 377 
products is correlated with reductions in carcinogenic impacts, non-carcinogenic impacts, and 378 
respiratory effects. However, the significant agricultural inputs associated with manufacturing 379 
biopolymers exacerbate environmental impacts of products and devices made out of 380 
biopolymers.  381 
 382 
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